Gushchin and Diaz-Montes Describe QOL Outcomes After Cytoreduction and HIPEC in Ovarian Cancer

Drs Gushchin and Diaz-Montes discuss findings from the HOT trial evaluating health-related quality of life outcomes after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with primary ovarian cancer.

Related Keywords

Baltimore ,Maryland ,United States ,Annapolis ,Ashling Wahner ,Vadim Gushchin ,Teresa Diaz Montes ,Neilb Rosenshein ,Linkedin ,Gynecologic Oncology Center At Mercy Medical ,Skin Cancer Center ,Institute For Gynecologic Care At Annapolis ,Lya Segall Ovarian Cancer Institute ,Facebook ,Twitter ,Gynecologic Oncology Annual Meeting ,Gastrointestinal Oncology ,Surgical Oncology ,Mercy Medical Center ,Gynecologic Care ,Gynecologic Oncology Center ,Mercy Medical ,Drs Gushchin ,Onclive State ,Science Summit ,Apple Podcasts ,Google Podcasts ,Amazon Music ,D ,Bph ,Iacog ,The Lya Segall Ovarian Cancer Institute ,The Neilb Rosenshein ,Hot Trial ,Nct02124421 ,Health Related Quality Of Life Outcomes After Cytoreductive Surgery And Hipec ,Patients With Primary Ovarian Cancer ,